Delta-like ligand 3
Showing 51 - 75 of >10,000
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare
Recruiting
- Salivary Gland Tumor
- Rare Malignant Neoplasm
- 68-Ga PSMA PET scan
-
Singapore, SingaporeNational Cancer Centre Singapore
Oct 11, 2022
Bariatric Surgery Trial in Hvidovre (Placebo, GLP-1 antagonism, GIP antagonism)
Completed
- Bariatric Surgery
- Placebo
- +3 more
-
Hvidovre, Denmark
- +1 more
Jan 31, 2022
Human Papillomavirus Vaccination Trial in Louise (Counseling)
Enrolling by invitation
- Human Papillomavirus Vaccination
- Counseling
-
Louise, MississippiPlan A Health, Inc
Dec 19, 2022
The Gut Microbiome and Immunotherapy Response in Solid Cancers
Recruiting
- Cancer
-
Galveston, TexasUniversity of Texas Medical Branch
Sep 15, 2023
Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)
Recruiting
- Normal Physiology
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Deprescription, Benzodiazepine (BZD) and Related Drugs Trial in Geneve (Thematic quality circles - Deprescription)
Recruiting
- Deprescription
- Benzodiazepine (BZD) and Related Drugs
- Thematic quality circles - Deprescription
-
Geneve, Petit Lancy, SwitzerlandRéseau de soins Delta SA
May 11, 2023
Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant
Active, not recruiting
- Coronavirus
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Recombinant novel coronavirus protein vaccine (CHO cells)
-
Wuhu, Anhui, ChinaWannan Medical College Yijishan Hospital
May 6, 2023
Serum Insulin-like Growth Factor Binding Protein-3 asPotential
Not yet recruiting
- Colorectal Cancer
- evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
- (no location specified)
May 6, 2023
Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Paclitaxel
- +4 more
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital ( Site 3700)
Jan 31, 2023
Marijuana Use, Cannabis Use, Cannabis Intoxication Trial (High THC/No CBD Marihuana, High THC/High CBD Marihuana, No THC/No CBD
Not yet recruiting
- Marijuana Use
- +2 more
- High THC/No CBD Marihuana
- +2 more
- (no location specified)
Jan 4, 2022
Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)
Not yet recruiting
- Chronic Hepatitis Delta Virus Infection
- HH-003(20mg/kg)
- +2 more
- (no location specified)
May 7, 2023
Squeaking in Ceramic-on-Ceramic Total Hip Arthroplasty Using
Recruiting
- Osteoarthritis, Hip
- +4 more
- Total hip arthroplasty with Delta TT cup
-
Seongnam, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Oct 24, 2022
Idiopathic Pulmonary Fibrosis Trial in Palo Alto (PLN-74809, Knottin tracer)
Completed
- Idiopathic Pulmonary Fibrosis
- PLN-74809
- Knottin tracer
-
Palo Alto, CaliforniaStanford Medical Center
Nov 15, 2022
DELTA DESCRIBE: THE FRENCH COLLABORATIVE PROJECT
Recruiting
- Hepatitis D
- Patients co-infected HBV/HDV
-
Limoges, FranceChu Limoges
Jun 27, 2023
Interventions on Admissional SOFA Score on Clinical Outcomes of
Not yet recruiting
- Critically Ill Patients
- Standardized interventions
- (no location specified)
Mar 29, 2023
Peripheral Serotonin and Albinism
Not yet recruiting
- Oculocutaneous Albinism
- Dosage of serotonin and metabolites
- Blood parameters
-
Paris, FranceHôpital Necker-Enfants Malades
Nov 14, 2023
Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC) Trial in
Recruiting
- Esophageal Squamous Cell Carcinoma (ESCC)
- +2 more
- pembrolizumab
- +7 more
-
Long Beach, California
- +158 more
Jan 19, 2023
Tumors, Head and Neck Trial in Worldwide (Dostarlimab, Belrestotug, GSK6097608)
Not yet recruiting
- Neoplasms, Head and Neck
- Dostarlimab
- +2 more
-
New Haven, Connecticut
- +121 more
Oct 3, 2023
Triple Negative Breast Cancer, PD-L1 Negative Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Paclitaxel,
Recruiting
- Triple Negative Breast Cancer
- PD-L1 Negative
- Sacituzumab Govitecan-hziy
- +4 more
-
Anchorage, Alaska
- +231 more
Jan 17, 2023
MDD, Anhedonia Trial in Chapel Hill (Cross-frequency transcranial alternating current stimulation via the NeuroConn Direct
Recruiting
- Major Depressive Disorder
- Anhedonia
- Cross-frequency transcranial alternating current stimulation via the NeuroConn Direct Current Stimulator Plus
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Oct 21, 2022
Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Carboplatin, Etoposide)
Not yet recruiting
- Small Cell Lung Carcinoma (SCLC)
- BI 764532
- +5 more
- (no location specified)
Oct 17, 2023
COVID-19 Trial in Barranquilla (Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron
Not yet recruiting
- COVID-19
- Trivalent COVID-19 Vaccine (Vero Cell), Inactivated, Prototype Strain, Delta Strain and Omicron Strain
- COVID-19 Vaccine (Vero Cell), Inactivated
-
Barranquilla, ColombiaClinica de la Costa
Jun 23, 2022
Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)
Not yet recruiting
- Relapsed/Refractory Large Granular T Lymphocytic Leukemia
-
Zhoukou, Henan, China
- +1 more
Dec 22, 2022
Pain, Tolerance, Oral vs Vaporized THC, Abuse Liability Trial in West Haven (Dronabinol 5 MG, Dronabinol 10 MG, 2mg Purified THC
Not yet recruiting
- Pain, Tolerance
- +2 more
- Dronabinol 5 MG
- +4 more
-
West Haven, ConnecticutVA Connecticut Healthcare System
Jun 15, 2023